NeuroDiscovery AI

NeuroDiscovery AI is a next-generation NeuroTech company that leverages a proprietary multi-modal Large Language Model (NeuroLLM™) and a vast repository of de-identified real-world data (RWD) from over 6 million neurology patient records. The company partners with leading U.S. outpatient neurology practices to accelerate clinical trial recruitment, generate real-world evidence, and drive implementation science for neurological conditions such as Alzheimer's, Parkinson's, epilepsy, migraine, and multiple sclerosis. By integrating EHR, imaging, and multi-omics data, the platform enables pharmaceutical companies and healthcare providers to compress clinical trial recruitment timelines significantly—from 18 months to as little as five to eight weeks. The company is currently expanding its capabilities to include biological sample storage and sequencing, with future plans to establish a dedicated brain research institute.